For your clinical trial, Teiko reports cells per microliter for gated populations and functional subsets, not only relative frequencies. Pair your complete blood count (CBC) or contract research organization (CRO) white blood cell (WBC) data with TokuKit cytometry so treatment effects show up as real cell numbers.
One for your CBC or CRO absolute count pathway, one for Teiko cytometry in TokuKit.
Provide specimen ID and WBC/µL (granulocytes, lymphocytes, monocytes optional).
See absolute counts next to frequencies for every gate and subset.
Pair CBC or CRO absolute count inputs with TokuKit cytometry to report cells/µL on every gate.
Follow your lab’s instructions for the absolute count pathway.
Learn about TokuKit sample prep →Preserve and optimize the sample for multi-parameter cytometry.
Specimen ID and WBC/µL required. Granulocytes, lymphocytes, and monocytes optional.
Teiko maps those inputs onto your gated populations.
Immune Boxplot, Immune Differences, Immune Changes Over Time, and data tables all carry cells/µL.
Relative frequency is a share of a parent gate. When the parent expands or contracts, a stable drug target can look like it fell, and a rising population can look flat.
Relative frequencies (incorrect) vs absolute counts (correct) — tables TBD.
Placeholder: draft comparison tables not yet built into this layout (image/curve slot retained).
A dedicated view reports cells per microliter for every profiled immune population, next to the relative frequencies you already use.
Range, median, and spread of absolute counts per gate.
.png)
Compare groups on absolute counts, and follow per-subject trajectories with timepoint comparisons.

Absolute counts reported as cells/µL. Dashboard figure placeholders retained from template; replace with absolute-count visuals later.
Explore the dashboard →Absolute cell counts support many translational questions. Here are three ways teams put them to work.
Detect expansion or depletion even when percentages barely move.
Track reconstitution after lymphodepletion or cell therapy in cells/µL, not only shares of a parent.
Correlate absolute counts with response, progression, or survival.
Share your trial design and sample plan, and our scientists will help add absolute counts alongside your frequency readout.